$0.64 -0.02 (-2.88%)
2/10/2012 3:57 PM

Biodel, Inc. (NASDAQ:BIOD)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company, which focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis.

Featured Broker Partners


Advertisement